Provectus Biopharmaceuticals Announces Presentation of Multiple Protein Kinase Signaling Targets, including WNK1, for PV-10® Immunotherapy at American Association for Cancer Research (AACR) 2022 Annual Meeting
April 11, 2022 07:30 ET
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, April 11, 2022 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that preclinical research on systemic administration of investigational cancer immunotherapy PV-10 (rose...
Historic Farm Resurrected as Largest Wedding Venue in Tennessee With Private Island
March 08, 2022 14:45 ET
|
Sandy Creek Farms
SPRINGVILLE, Tenn., March 08, 2022 (GLOBE NEWSWIRE) -- A historic farm is currently being resurrected as the largest wedding venue and lodging hot spot in Springville, Tennessee. Sandy Creek Farms...
Food Lion Feeds Donates $50,000 to Feeding America Kentucky’s Heartland for Tornado Rebuilding Efforts
February 18, 2022 15:14 ET
|
Food Lion
SALISBURY, N.C., Feb. 18, 2022 (GLOBE NEWSWIRE) -- Food Lion Feeds presented Feeding America, Kentucky’s Heartland (FAKH) with a check for $50,000 to help rebuild the Purchase Area Development...
Provectus Biopharmaceuticals Announces Acceptance of PV-10® Metastatic Uveal Melanoma Abstract for Oral Presentation at 2022 International Society of Ocular Oncology (ISOO) Congress
February 16, 2022 09:00 ET
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that data from an ongoing clinical trial of investigational cancer immunotherapy PV-10 for the treatment of...
Provectus Biopharmaceuticals Announces Acceptance of PV-10® Systemic Administration Abstract at American Association for Cancer Research (AACR) Annual Meeting 2022
February 08, 2022 05:00 ET
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Feb. 08, 2022 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that preclinical research on systemic administration of investigational cancer immunotherapy PV-10 (rose...
Provectus Biopharmaceuticals Provides Update on Research into PV-10® Immunotherapy as an Immune Adjuvant for Making Vaccines Work Better
January 27, 2022 08:00 ET
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today provided an update on research of its investigational immunotherapy PV-10 (rose bengal sodium, a halogenated xanthene...
New No-Contact Delivery Service for Propane Grill Tanks Arrives in Nashville Area
January 25, 2022 10:16 ET
|
Cynch
VALLEY FORGE, Pa., Jan. 25, 2022 (GLOBE NEWSWIRE) -- AmeriGas Propane – Today Cynch, the propane grill tank delivery service, announced its expansion into the Nashville market. During a time of...
Odyssey Behavioral Healthcare Opens Selah House Outpatient Treatment Clinic in Jeffersonville, Indiana
January 18, 2022 10:00 ET
|
Odyssey Behavioral Healthcare
BRENTWOOD, Tenn., Jan. 18, 2022 (GLOBE NEWSWIRE) -- Odyssey Behavioral Healthcare ("Odyssey") is pleased to announce the opening of their newest Selah House Outpatient location in Jeffersonville,...
7 Springs Orthopedics Acquires Sport Ortho Urgent Care to Form One of the Largest Orthopedic Footprints in the State of Tennessee
January 18, 2022 07:00 ET
|
Sport Ortho Urgent Care
BRENTWOOD, Tenn., Jan. 18, 2022 (GLOBE NEWSWIRE) -- On Dec. 7, 2021, 7 Springs Orthopedics completed the acquisition of Sport Ortho Urgent Care in order to form one of the largest orthopedic...
Martin & Company Advertising Announces – Randy Martin Memorial Arts Scholarship to Benefit UT Southern is Halfway to Goal
December 20, 2021 15:22 ET
|
Martin & Company
WHITES CREEK, Tenn., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Martin & Company (M&C), a full-service marketing solutions firm specializing in both traditional and digital branding for the...